Tinea capitis

Cutis

Volumn 78, Issue 3, 2006, Pages 189-196

  Alvarez, Marcy S ^a   Silverberg, Nanette B ^b,c,d,e  

^a LUTHERAN MEDICAL CENTER   (United States)

^b New York Presbyterian Columbia University Medical Center   (United States)

^c ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^d MAIMONIDES MEDICAL CENTER   (United States)

^e BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; GRISEOFULVIN; ITRACONAZOLE; NAPHTHALENE DERIVATIVE; TERBINAFINE;

HEALTH; HUMAN; MICROBIOLOGY; MICROSPORUM; PATHOLOGY; REVIEW; TINEA CAPITIS; TRICHOSPORON; UNITED STATES;

ANTIFUNGAL AGENTS; FLUCONAZOLE; GRISEOFULVIN; HUMANS; ITRACONAZOLE; MICROSPORUM; NAPHTHALENES; TINEA CAPITIS; TRICHOSPORON; UNITED STATES; WORLD HEALTH;

EID: 33749241545     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Ghannoum M, Isham N, Hajjeh R, et al. Tinea capitis in Cleveland: survey of elementary school students. J Am Acad Dermatol. 2003;48:189-193.
2. Sharma V, Silverberg NB, Howard R, et al. Do hair care practices affect the acquisition of tinea capitis? a case-control study. Arch Pediatr Adolesc Med. 2001;155:818-821.
3. Elewski BE. Tinea capitis: a current perspective. J Am Acad Dermatol. 2000;42:1-20.
4. Rasmussen JE, Ahmed AR. Trichophyton reactions in children with tinea capitis. Arch Dermatol. 1978;114:371-372.
5. Menan EI, Zongo-Bonou O, Rouet F, et al. Tinea capitis in schoolchildren from Ivory Coast (western Africa): a 1998-1999 cross-sectional study. Int J Dermatol. 2002;41:204-207.
6. Romano C, Gianni C, Papini M. Tinea capitis in infants less than 1 year of age. Pediatr Dermatol. 2001;18:465-468.
7. Ismail F, Fuller C, Moore M. Infants with tinea capitis: experience from the GKT Medical School mycology department. Pediatr Dermatol. 2003;20:283-284.
8. Raimer SS, Beightler EL, Hebert AA, et al. Tinea faciei in infants caused by Trichophyton tonsurans. Pediatr Dermatol. 1986;3:452-454.
9. Silverberg NB, Weinberg JM, DeLeo VA. Tinea capitis: focus on African American women. J Am Acad Dermatol. 2002;46(suppl 2):S120-S124.
10. Rothman S, Smiljanic A, Shapiro AL, et al. The spontaneous cure of tinea capitis at puberty. J Invest Dermatol. 1947;8:81-98.
11. Takwale A, Agarwal S, Holmes SC, et al. Tinea capitis in two elderly women: transmission at the hairdresser. Br J Dermatol. 2001;144:898-900.
12. Pursley TV, Raimer SS. Tinea capitis in the elderly. Int J Dermatol. 1980;19:220.
13. Terragni L, Lasagni A, Oriani A. Tinea capitis in adults. Mycoses. 1989;32:482-486.
14. Cremer G, Bournerias I, Vandemeuleubroucke E, et al. Tinea capitis in adults: misdiagnosis or reappearance? Dermatology. 1997;194:8-11.
15. Martin ES, Elewski BE. Tinea capitis in adult women masquerading as bacterial pyoderma. J Am Acad Dermatol. 2003;49(suppl 2):S177-S179.
16. Bronson DM, Desai DR, Barsky S, et al. An epidemic of infection with Trichophyton tonsurans revealed in a 20-year survey of fungal infections in Chicago. J Am Acad Dermatol. 1983;8:322-330.
17. Lee JY, Hsu ML. Tinea capitis in Southern Taiwan. Int J Dermatol. 1991;30:572-575.
18. Shiraki Y, Hiruma M, Hirose N, et al. A nationwide survey of Trichophyton tonsurans infection among combat sport club members in Japan using a questionnaire form and the hairbrush method. J Am Acad Dermatol. 2006;54:622-626.
19. McLean T, Levy H, Lue YA. Ecology of dermatophyte infections in South Bronx, New York, 1969 to 1981. J Am Acad Dermatol. 1987;16(2 pt 1):336-340.
20. Lobato MN, Vugia DJ, Frieden IJ. Tinea capitis in California children: a population-based study of a growing epidemic. Pediatrics. 1997;99:551-554.
21. Koussidou-Eremondi T, Devliotou-Panagiotidou D, Mourellou-Tsatsou O, et al. Tinea capitis in children in northern Greece during the period 1981-1995. Mycoses. 1999;42:319-322.
22. Friedlander SF, Rueda M, Chen BK, et al. Fungal, protozoal, and helminthic infections. In: Schachner LA, Hansen RC. Pediatric Dermatology. 3rd ed. Philadelphia, Pa: Elsevier; 2003:1093-1100.
23. Rudolph AH. The clinical recognition of tinea capitis from Trichophyton tonsurans [editorial]. JAMA. 1979;242:1770.
24. Georg LK. Trichophyton tonsurans ringworm: a new public health problem. Public Health Rep. 1952;67:53-56.
25. Provost E. Nonfluorescent tinea capitis in Charleston, SC. JAMA. 1979;242:1765-1767.
26. Foster KW, Ghannoum MA, Elewski BE. Epidemiologic surveillance of cutaneous fungal infection in the United States from 1999 to 2002. J Am Acad Dermatol. 2004;50:748-752.
27. Moore MK, Suite M. Tinea capitis in Trinidad. J Trop Med Hyg. 1993;96:346-348.
28. Foster KW, Ghannoum MA, Elewski B. Epidemiologic surveillance of cutaneous fungal infection in the United States from 1999 to 2002. J Am Acad Dermatol 2004;50:748-752.
29. Markey RJ, Staat MA, Gerrety MJ, et al. Tinea capitis due to Trichophyton soudanense in Cincinnati, Ohio, in internationally adopted children from Liberia. Pediatr Dermatol. 2003;20:408-410.
30. Schwinn A, Ebert J, Brocker EB. Frequency of Trichophyton rubrum in tinea capitis. Mycoses. 1995;38:1-7.
31. Viguie-Vallanet C, Serre M, Masliah L, et al. Epidemic of Trichophyton tonsurans tinea capitis in nursery school in the southern suburbs of Paris [in French]. Ann Dermatol Venereol. 2005;132:432-438.
32. Garg AP, Muller J. Inhibition of growth of dermatophytes by Indian hair oils. Mycoses. 1992;35:363-369.
33. Pomeranz AJ, Sahnis SS, McGrath OJ, et al. Asymptomatic dermatophyte carriers in the households of children with tinea capitis. Arch Pediatr Adolesc Med. 1999;153:483-486.
34. Vargo K, Cohen RA. Prevalence of undetected tinea capitis in household members of children with disease. Pediatrics. 1993;92:155-157.
35. Ive FA. The carrier stage of tinea capitis in Nigeria. Br J Dematol. 1996;78:219-221.
36. Sharma V, Hall JC, Knapp JF, et al. Scalp colonization by Trichophyton tonsurans in an urban pediatric clinic, asymptomatic carrier state. Arch Dermatol. 1988;124:1511-1513.
37. Neil G, Hanslo D, Buccimazza S, et al. Control of the carrier state of scalp dermatophytes. Pediatr Infect Dis J. 1990;9:57-58.
38. Williams JV, Honig PJ, McGinley KJ, et al. Semiquantitative study of tinea capitis and the asymptomatic carrier state in inner-city school children. Pediatrics. 1995;96:265-267.
39. Midgely G, Clayton YM. Distribution of dermatophytes and Candida spores in the environment. Br J Dermatol. 1972;86:69-77.
40. Pipkin JL. Tinea capitis in the adult and adolescent. AMA Arch Derm Syphilol. 1952;66:9-40.
41. Honig PJ, Sullivan K, McGowan KL. The rapid diagnosis of tinea capitis using calcofluor white. Pediatr Emerg Care. 1996;12:333-335.
42. Friedlandcr SF, Pickering B, Cunningham BB, et al. Use of the cotton swab method in diagnosing tinea capitis. Pediatrics. 1999;104:276-279.
43. Allen AM, Taplin D, Lowy JA, et al. Skin infections in Vietnam. Mil Med. 1972;137:295-301.
44. Gromadzki S, Ramani R, Chaturvedi V. Evaluation of new medium for identification of dermatophytes and primary dimorphic pathogens. J Clin Microbiol. 2003;41:467-468.
45. Sheretz EF. Are laboratory studies necessary for griseofulvin therapy? J Am Acad Dermatol. 1990;22:1103.
46. Gupta AK, Adam P, Dlova N, et al. Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole. Pediatr Dermatol. 2001;18:433-438.
47. Physicians' Desk Reference. 58th ed. Montvale, NJ: Thomson, 2004.
48. Williams DI, Marten RH, Sarkany I. Oral treatment of ringworm with griseofulvin. Lancet. 1958;2:1212-1213.
49. Dastghaih L, Azizzadeh M, Jafari P. Therapeutic options for the treatment of tinea capitis: griseofulvin versus fluconazole. J Dermatol Treat. 2005;16:43-46.
50. Epstein WL, Shah VP, Riegelman S. Griseofulvin levels in stratum corneum. Arch Dermatol. 1960;81:662-666.
51. Sobue S, Sekiguchi K, Nabeshima T. Intracutaneous distributions of fluconazole, itraconazole, and griseofulvin in Guinea pigs and binding to human stratum corneum. Antimicrob Agents Chemother. 2004;48:216-223.
52. Colton RL, Amir J, Mimouni M, et al. Serum sickness-like reaction associated with griseofulvin. Ann Pharmacother. 2004;38:609-611.
53. Chan YC, Friedlander SF. New treatments for tinea capitis. Curr Opin Infect Dis. 2004;17:97-103.
54. Abdel-Rahman SM, Powell DA, Nahata MC. Efficacy of itraconazole in children with Trichophyton tonsurans tinea capitis. J Am Acad Dermatol. 1998;38:443-446.
55. Ahmad SR, Singer SJ, Leissa BG. Congestive heart failure associated with itraconazole. Lancet. 2001;2357:1766-1767.
56. Haedersdal M, Svejgaard EL. Once-weekly fluconazole in children with tinea capitis due to Microsporum canis. Acta Derm Venereol. 2005;85:177-178.
57. Gupta AK, Dlova N, Taborda P, et al. Once weekly fluconazole is effective in children in the treatment of tinea capitis: a prospective, multicentre study. Br J Dermatol. 2000;142:965-968.
58. Devliotou-Panagiotidou D, Koussidou-Eremondi TH. Efficacy and tolerability of 8 weeks' treatment with terbinafine in children with tinea capitis caused by Microsporum canis: a comparison of three doses. J Eur Acad Dermatol. 2004;18:155-159.
59. Fleece D, Gaughan JP, Aronoff SC. Griseofulvin versus terbinafine in the treatment of tinea capitis: a meta-analysis of randomized, clinical trials. Pediatrics. 2004;114:1312-1315.
60. Allen HB, Honig PJ, Leyden JJ, et al. Selenium sulfide: adjunctive therapy for tinea capitis. Pediatrics. 1982;69:81-83.
61. Greer DL. Successful treatment of tinea capitis with 2% ketoconazole shampoo. Int J Dermatol. 2000;39:302-304.
62. Warner RR, Schwartz JR, Boissy Y, et al. Dandruff has an altered stratum corneum infrastructure that is improved with zinc pyrithione shampoo. J Am Acad Dermatol. 2001;45:897-903.
63. Ginsburg CM, Gan VN, Petruska M. Randomized controlled trial of intralesional corticosteroid and griseofulvin vs. griseofulvin alone for treatment of kerion. Pediatr Infect Dis J. 1987;6:1084-1087.